Eye dryness risk during angioplasty: study tests dexmedetomidine vs. standard sedation
NCT ID NCT07326332
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares how two types of sedation affect tear production in 52 adults undergoing angioplasty. One group gets dexmedetomidine, the other gets standard sedatives like midazolam and fentanyl. Tear production is measured before, right after, and 12 hours after the procedure. The goal is to see if dexmedetomidine causes less eye dryness, which could improve patient comfort during these common heart procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dexmedetomidine
- What this could lead to
- If it works, this could help doctors choose sedatives that keep eyes more comfortable during procedures like angioplasty.
- What could go wrong
- This is a small, early-stage study with only 52 participants, so results may not apply to everyone. It looks at a temporary effect, not a long-term treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TEAR FILM ALTERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Benha University Hospital
Banhā, Qalyubia Governorate, 13511, Egypt